Clinical trial
Enbrel® in Psoriatic Arthritis
NCT00111124 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00111124 |
|---|---|
| Title | Enbrel® in Psoriatic Arthritis |
| Official title | Enbrel® in Psoriatic Arthritis |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Psoriasis |
| Intervention type | Drug |
| Interventions | Enbrel® |
| First posted | May 18, 2005 |
| Last update posted | May 15, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: